Cargando…
Barriers to drug adherence in the treatment of urea cycle disorders: Assessment of patient, caregiver and provider perspectives
Patients and families living with metabolic disorders face challenging dietary and drug treatment regimens. On the hypothesis that poor palatability, volume and frequency of drug/formula administration contribute to treatment non-adherence and hyperammonemic episodes, a survey was conducted of patie...
Autores principales: | Shchelochkov, Oleg A., Dickinson, Klara, Scharschmidt, Bruce F., Lee, Brendan, Marino, Miguel, Le Mons, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963256/ https://www.ncbi.nlm.nih.gov/pubmed/27493880 http://dx.doi.org/10.1016/j.ymgmr.2016.07.003 |
Ejemplares similares
-
Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate()
por: Hook, Debra, et al.
Publicado: (2016) -
Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate
por: Mokhtarani, M., et al.
Publicado: (2015) -
BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS
por: Lee, Brendan, et al.
Publicado: (2014) -
The Urea Cycle
por: Seashore, Margretta R.
Publicado: (1978) -
Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers
por: Holbrook, Anne, et al.
Publicado: (2021)